MIAMI, FL, UNITED STATES, December 30, 2025 /EINPresswire.com/ — AIdMD Technologies is pleased to announce the U.S. market launch of its artificial intelligence–powered healthcare platform, ...

Designed to empower users to understand the causes of their headaches, the app now includes a suite of tools to log symptoms, analyze, track treatment efficacy We created this app to address a very ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...

Background Patients and families from culturally and linguistically diverse (CALD) backgrounds face distinct challenges ...

Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Across healthcare, providers are rapidly deploying tools such as ambient clinical documentation, while payers are adopting AI-powered agents for a growing range of operational and administrative use ...

The NHS has an extraordinary opportunity in 2026. Unified data, decision intelligence, and strong workforce capability can ...

Panelists discuss how pivotal RVO trial data for aflibercept 8 mg show strong durability and visual outcomes while raising ...

OTO Fertility, a digital health platform developed by OTO Coach, is setting a new standard of care with patented biometric data and AI-powered insight to predict fertility treatment outcomes. Designed ...

Highlights significant progress in 2025 and outlines commercial priorities and potential catalysts entering 2026 ...